QUILTMAN: Very pessimistic numbers !I think that Abiomed has...

First 18 Last

Share
Profile

Follow
dpdebrec

520 Posts.

219

27/07/21

07:12

Post #: 54792634
Share

Originally posted by Quiltman: ↑

This is the price to sales ratio for the semiconductor industry. Other than Q2 slump, around 10. So lets go with that as should return as supply stabliises.

Our booked Q4 sales A$840k, Annualised $3.4M / 340M Shares =.01 x 10 = $.10c per share ( currently 4, which is interesting based on above )
AbioMed $4M annual + $1M R&D Work = $5M/ 340M Shares = $.15c per share
Lets add $2M OneTouch CGM to that = 7/340 = $.205c per share

And then there is that company, what are they called again, oh yeah, NanoDX.
Double it, $14M sales, $.42c per share ... a Disallowed from here.

Very possible.

IMO

Expand

QUILTMAN: Very pessimistic numbers !

I think that Abiomed has indicated demand for 2022 in excess of USD 4 mill which equates to at least A$ 5.4 mill. alone.

If NanoDx gets EUA, I think we will be looking at sales to NanoDx of greater than A$ 7 mill (approx USD 5 mill).

BUT lets stick to the conservative side.
We won't discuss where the stock price should be if sales for C2022 will exceed USD 20 mill !!

KUNKBA:

By now BLIND FREDDY can see the manipulating sell orders, so I do not think that the posters need my running commentary.
Any order in excess of 600k that is placed at least 0.5 c above the market price are ...........

BTW I believe the seller in the last 45 minutes that sold approx 580k shares at 4.2 & 4.1 was a daytrader that picked them in the first half hour of trading at a similar price.

SE1 Price at posting: 4.1¢ Sentiment: Buy Disclosure: Held
8 Upvote

1 Great analysis

Reply